Boston Scientific lands Euro approval for Precision Spectra spinal cord stim
Medical device company Boston Scientific wins European regulatory approval for its Precision Spectra spinal cord stimulation system.
Medtech titan Boston Scientific [1] (NYSE:BSX [2]) won European regulatory approval for its Precision Spectra spinal cord stimulation system, the company announced today.
The Precision Spectra was cleared for treatment of patients suffering from chronic pain, and the 1st commercial implant of the device was performed in the U.K. last month, according to a press release.